Allgens Medical Technology CO., LTD. (SHA:688613)
China flag China · Delayed Price · Currency is CNY
24.28
+0.16 (0.66%)
Jan 23, 2026, 3:00 PM CST

SHA:688613 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
3,3272,4452,9683,1237,368-
Upgrade
Market Cap Growth
32.65%-17.61%-4.95%-57.62%--
Upgrade
Enterprise Value
2,3351,4531,9602,1596,416-
Upgrade
Last Close Price
24.2818.0422.1523.2054.19-
Upgrade
PE Ratio
--54.7332.8061.00-
Upgrade
Forward PE
-30.8430.8430.8440.78-
Upgrade
PS Ratio
15.5611.8713.1112.7331.21-
Upgrade
PB Ratio
2.301.722.112.365.80-
Upgrade
P/TBV Ratio
2.401.812.182.446.04-
Upgrade
P/FCF Ratio
--99.6855.14107.50-
Upgrade
P/OCF Ratio
--57.4330.6056.78-
Upgrade
EV/Sales Ratio
10.927.058.658.8027.18-
Upgrade
EV/EBITDA Ratio
--63.6124.5153.01-
Upgrade
EV/EBIT Ratio
--122.3329.2258.17-
Upgrade
EV/FCF Ratio
-96.27-65.8238.1393.60-
Upgrade
Debt / Equity Ratio
0.030.040.040.050.060.11
Upgrade
Debt / EBITDA Ratio
28.84-1.570.670.650.64
Upgrade
Debt / FCF Ratio
--1.791.091.182.44
Upgrade
Asset Turnover
0.140.130.150.170.210.24
Upgrade
Inventory Turnover
1.121.361.542.191.742.04
Upgrade
Quick Ratio
16.4821.6822.8423.0319.887.34
Upgrade
Current Ratio
17.8822.8923.6423.5720.327.77
Upgrade
Return on Equity (ROE)
-0.40%-1.21%3.88%7.06%12.29%14.34%
Upgrade
Return on Assets (ROA)
-0.75%-1.12%0.67%3.20%6.18%7.87%
Upgrade
Return on Invested Capital (ROIC)
-4.22%-6.98%4.73%23.59%38.27%40.37%
Upgrade
Return on Capital Employed (ROCE)
-1.30%-1.80%1.10%5.20%8.00%13.10%
Upgrade
Earnings Yield
-0.11%-0.52%1.83%3.05%1.64%-
Upgrade
FCF Yield
-0.73%-1.35%1.00%1.81%0.93%-
Upgrade
Dividend Yield
--0.27%0.46%0.50%-
Upgrade
Payout Ratio
--31.47%42.14%1.03%1.57%
Upgrade
Buyback Yield / Dilution
-22.74%-6.36%1.37%-12.14%-19.66%0.06%
Upgrade
Total Shareholder Return
-22.74%-6.36%1.64%-11.68%-19.16%0.06%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.